AKEBIA THERAPEUTICS, INC. Debt Securities, Available-for-sale, Noncurrent
AKEBIA THERAPEUTICS, INC. (AKBA) had Debt Securities, Available-for-sale, Noncurrent of $245.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2019-03-26
- 2018-12-31: Debt Securities, Available-for-sale, Noncurrent $245.00K.
- 2018-09-30: Debt Securities, Available-for-sale, Noncurrent $14.99M.
- 2018-06-30: Debt Securities, Available-for-sale, Noncurrent $32.17M.
- 2018-03-31: Debt Securities, Available-for-sale, Noncurrent $43.59M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2018-12-31 | $245.00K 10-K · filed 2019-03-26 |
| 2018-09-30 | $14.99M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $32.17M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $43.59M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $29.75M 10-K · filed 2018-03-12 |
| 2017-09-30 | $22.68M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $4.64M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $12.71M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $7.94M 10-K · filed 2017-03-06 |
| 2016-09-30 | $16.67M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $27.58M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $50.61M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $49.60M 10-K · filed 2016-03-14 |
| 2015-09-30 | $50.97M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $38.76M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $33.10M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $39.85M 10-K · filed 2015-03-04 |
| 2014-09-30 | $41.34M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $18.96M 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |